Carlsmed Inc [NASDAQ: CARL] price plunged by -2.85 percent to reach at -$0.39.
A sum of 156992 shares traded at recent session while its average daily volume was at 306.63K shares. Carlsmed Inc shares reached a high of $13.65 and dropped to a low of $12.16 until finishing in the latest session at $13.3.
The one-year CARL stock forecast points to a potential upside of 27.72. The average equity rating for CARL stock is currently 1.00, trading closer to a bullish pattern in the stock market.
Guru’s Opinion on Carlsmed Inc [CARL]:
Based on careful and fact-backed analyses by Wall Street experts, the current consensus on the target price for CARL shares is $18.40 per share. Analysis on target price and performance of stocks is usually carefully studied by market experts, and the current Wall Street consensus on CARL stock is a recommendation set at 1.00. This rating represents a strong Buy recommendation, on the scale from 1 to 5, where 5 would mean strong sell, 4 represents Sell, 3 is Hold, and 2 indicates Buy.
Truist have made an estimate for Carlsmed Inc shares, keeping their opinion on the stock as Buy, with their previous recommendation back on August 18, 2025. While these analysts kept the previous recommendation, Piper Sandler raised their target price to Overweight. The new note on the price target was released on August 18, 2025, representing the official price target for Carlsmed Inc stock. Previously, the target price had yet another raise to $19, while Goldman analysts kept a Buy rating on CARL stock.
CARL Stock Performance Analysis:
Carlsmed Inc [CARL] gain into the green zone at the end of the last week, gaining into a positive trend and gaining by 1.99.
Overbought and oversold stocks can be easily traced with the Relative Strength Index (RSI), where an RSI result of over 70 would be overbought, and any rate below 30 would indicate oversold conditions. An RSI rate of 50 would represent a neutral market momentum. The current RSI for CARL stock in for the last two-week period is set at 45.22, with the RSI for the last a single of trading hit 0.91, and the three-weeks RSI is set at 0.82 for Carlsmed Inc [CARL]. The present Moving Average recorded at 13.80 for the last single week of trading.
Insight into Carlsmed Inc Fundamentals:
Operating Margin for any stock indicates how profitable investing would be, and Carlsmed Inc [CARL] shares currently have an operating margin of -64.53% and a Gross Margin at 74.28%. Carlsmed Inc’s Net Margin is presently recorded at -66.92%.
Carlsmed Inc (CARL) Capital Structure & Debt Analysis
According to recent financial data for Carlsmed Inc. ( CARL), the Return on Equity (ROE) stands at -212.36%, highlighting a negative impact on investor capital. The Return on Assets (ROA) is -73.68%, reflecting the company’s efficiency in generating profits from its assets. Additionally, Carlsmed Inc’s Return on Invested Capital (ROIC) is -59.85%, showcasing its effectiveness in deploying capital for earnings.
Carlsmed Inc (CARL) Efficiency & Liquidity Metrics
Based on Carlsmed Inc’s (CARL) latest financial statements, the Debt-to-Equity Ratio is 0.69%, indicating its reliance on debt financing relative to shareholder equity.
Carlsmed Inc (CARL) Efficiency & Liquidity Metrics
From an operational efficiency perspective, Carlsmed Inc. (CARL) effectively leverages its workforce, generating an average of -$287752.81 per employee. The company’s liquidity position is robust, with a Current Ratio of 4.87% and a Quick Ratio of 4.76%, indicating strong ability to cover short-term liabilities.
CARL Stock EPS
With the latest financial reports released by the company, Carlsmed Inc posted -1.37/share EPS, while the average EPS was predicted by analysts to be reported at -0.92/share. When compared, the two values demonstrate that the company fail the estimates by a Surprise Factor of -0.45. The progress of the company may be observed through the prism of EPS growth rate, while Wall Street analysts are focusing on predicting the 5-year EPS growth rate for CARL.
Carlsmed Inc [CARL] Institutonal Ownership Details
There are presently around $0.42%, or 0.72%% of CARL stock, in the hands of institutional investors.
